Toward a cell-based cure for diabetes: advances in production and transplant of beta cells.

The Mount Sinai Journal of Medicine, New York
Kathryn C Claiborn, Doris A Stoffers

Abstract

Type 1 diabetes results from autoimmune destruction of the insulin-producing beta cells of the pancreatic islets of Langerhans. Although developments in exogenous insulin therapy have greatly improved clinical outcomes in patients with diabetes, the ability of the pancreatic beta cell to exquisitely regulate the delivery of insulin and maintain normal levels of blood glucose is still far superior to what can be achieved by external delivery of insulin. As a result, the majority of patients with type 1 diabetes still experience the complications of chronic hyperglycemia or serious and potentially life-threatening hypoglycemia. The shortcomings of medical therapy have driven research toward more direct approaches of beta cell replacement. Indeed, the specificity of beta cell loss in type 1 diabetes makes this disease a particularly attractive candidate for cell-based therapies. In order for significant progress to be made, however, a thorough understanding of beta cell biology and more broadly islet biology is necessary. This review addresses recent advances in developmental biology that have expanded our understanding of islet cell differentiation, assesses the promise and limitations of islet transplantation, and discusses the ...Continue Reading

References

Apr 1, 1988·Diabetes·C RicordiD W Scharp
Jun 1, 1994·Developmental Dynamics : an Official Publication of the American Association of Anatomists·H L Kaung
Jun 17, 1998·Genes & Development·M HebrokD A Melton
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·R G BretzelM D Brendel
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M C AngelicoC Ricordi
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·R P LanzaW L Chick
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·G GradwohlF Guillemot
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Bonner-WeirJ J O'Neil
Mar 20, 2002·Developmental Biology·Philip J diIorioLarry G Moss
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lijun YangAmmon B Peck
Nov 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yuichi HoriSeung K Kim
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
May 31, 2003·The Journal of Biological Chemistry·Idit BerSarah Ferber
Jun 20, 2003·Current Biology : CB·Eckhard LammertDouglas A Melton
Aug 15, 2003·Molecular and Cellular Biology·Taka-aki MatsuokaRoland Stein
Oct 17, 2003·Genes & Development·Patrick CollombatPeter Gruss
Oct 23, 2003·Annual Review of Cell and Developmental Biology·L Charles Murtaugh, Douglas A Melton
Feb 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Catherine L PradoLori Sussel
Sep 17, 2004·The Journal of Clinical Investigation·Rohit N KulkarniC Ronald Kahn
Oct 7, 2004·The Journal of Clinical Investigation·Kristina I Rother, David M Harlan
Nov 25, 2004·American Journal of Physiology. Endocrinology and Metabolism·Marcela BrissovaAlvin C Powers
Jun 29, 2005·Diabetes·Edmond A RyanA M James Shapiro
Aug 27, 2005·Developmental Biology·R Scott HellerPalle Serup
Oct 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kohtaro MinamiSusumu Seino
Jun 17, 2006·Cloning and Stem Cells·Xiaofang XuJon Odorico
Sep 20, 2006·Endocrine Journal·Satoko YamadaItaru Kojima

❮ Previous
Next ❯

Citations

Nov 28, 2012·Therapeutic Advances in Endocrinology and Metabolism·Mansur Shomali
Jul 12, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Armin MooranianHani Al-Salami
Jun 24, 2009·Nature Reviews. Endocrinology·Zdravka Medarova, Anna Moore
Mar 9, 2017·American Journal of Physiology. Endocrinology and Metabolism·Abdul Bari MuhammadXianxin Hua
Jul 1, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.